Cargando…
Acute Hemodynamic Changes after Single Administration of Udenafil in Pulmonary Arterial Hypertension: a Phase IIa Study
BACKGROUND AND OBJECTIVES: Udenafil, a new phosphodiesterase-5 inhibitor (PDE5i), has been used to treat erectile dysfunction. Given the proven benefit of PDE5i in pulmonary arterial hypertension (PAH), we evaluated serial hemodynamic changes after single udenafil administration to determine the app...
Autores principales: | Chang, Sung-A, Kim, Hyung-Kwan, Chang, Hyuk Jae, Kim, Duk-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428952/ https://www.ncbi.nlm.nih.gov/pubmed/30808080 http://dx.doi.org/10.4070/kcj.2018.0281 |
Ejemplares similares
-
Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019) -
A pilot study to explore the effect of udenafil on cerebral hemodynamics in older adults
por: Wang, Qi, et al.
Publicado: (2023) -
Udenafil for the treatment of erectile dysfunction
por: Cho, Min Chul, et al.
Publicado: (2014) -
ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial
por: Kim, Kyung-Hee, et al.
Publicado: (2013) -
Udenafil Induces the Hair Growth Effect of Adipose-Derived Stem Cells
por: Choi, Nahyun, et al.
Publicado: (2019)